ReviewFrontiers in oncology2023

Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.

Dennis Christoph Harrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.